Dr. Bořivoj Vojtěšek, Member

Head of Department of Molecular Oncology, Masaryk Memorial Cancer Institute, Brno, Czech Republic.

Dr. Vojtěšek is an expert in: tumour biology; the role of tumour supressor genes in the malignant transformation of the cell; proteomic approaches to biomarkers discovery; polyclonal and monoclonal antibodies development including those with potential in biological therapy; cell cycle analysis and functional studies leading to analysis of function of newly developed anticancer drugs.

Prof. Dr. Bohuslav Melichar, Member

Head of the Oncological Clinic, Faculty Hospital, Palacký University, Olomouc, Czech Republic.

Prof. Melichar is an expert in cancer pathology, clinical trials of new therapeutics and cancer treatments;

Prof. Dr. Zdeněk Kolář, Member

Dean of the Faculty of Medicine and Dentistry, Head of the Institute of Pathology, Palacký University, Olomouc, Czech Republic.

Prof. Kolář is an expert in molecular pathology of cancer, the role of nuclear receptors in cancer, and cancer stem cells and differentiation;

Dr. Michal Svoboda, Member

Science and Technology Officer at Circle Line Associates, Prague, Czech Republic.

Dr. Svoboda is an expert in preclinical and early clinical research and development projects in the field of oncology and infectology of NME related to pharmaceutical technology and analytical chemistry;

Dr. Adolf Mistr, Member

Drug Development Officer at Mistr Ltd., Brno, Czech Republic.

Dr. Mistr is an expert in the research and development of new drugs, including anticancer drugs and the management of preclinical studies.